A team from the University of Pennsylvania developed gum that delivers antiviral proteins directly into your mouth. This method targets viruses exactly where they multiply and spread. Chewing gum ...

NanoViricides, Inc., a publicly traded company (NYSE Amer.:NNVC) (the “Company”), and a leading global pioneer in the development of broad-spectrum antivirals based on host-mimetic nanomedicine ...

In one of their earlier studies, the Penn team added an antiviral protein called CTB-ACE2 to gum, which neutralized over 95 percent of SARS-CoV-2 particles in the saliva of COVID-19 patients ...